Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Investors with an eye on the healthcare sector might find ICU Medical, Inc. (NASDAQ: ICUI) an intriguing opportunity, particularly with its substantial potential upside of 52.96%. Headquartered in San Clemente,..
Liquidia Corporation (NASDAQ: LQDA) stands at an intriguing juncture in the biotechnology sector, boasting a market capitalization of $2.05 billion. Investors are increasingly eyeing this U.S.-based biopharmaceutical company, driven by..
Astrana Health Inc. (NASDAQ: ASTH), a rising star in the healthcare management sector, is catching the eye of investors with its compelling growth metrics and substantial potential upside. Headquartered in..
Novavax, Inc. (NVAX), a prominent player in the biotechnology sector, is making waves with its innovative approach to vaccine development. Headquartered in Gaithersburg, Maryland, Novavax engages in discovering, developing, and..
PACS Group, Inc. (PACS), a player in the healthcare sector specializing in medical care facilities, has caught the attention of investors with its significant potential upside. Based in Farmington, Utah,..
PTC Therapeutics, Inc. (NASDAQ: PTCT) stands as a notable player within the biotechnology sector, renowned for its dedication to addressing rare disorders through innovative therapies. With a market capitalization of..
LivaNova PLC (NASDAQ: LIVN), a medical technology powerhouse headquartered in London, is gaining traction among investors, boasting a significant potential upside of 25.34%. This intriguing figure, derived from an average..
Twist Bioscience Corporation (NASDAQ: TWST), a prominent player in the healthcare sector, specializing in diagnostics and research, is capturing the attention of investors with its innovative synthetic DNA-based products. The..
GoodRx Holdings, Inc. (NASDAQ: GDRX) is a notable player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $1.45 billion, GoodRx stands out..
For investors eyeing opportunities in the healthcare sector, Phreesia, Inc. (NYSE: PHR) presents a compelling proposition. With a market capitalization of $1.33 billion, this healthcare information services company is at..
Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a cutting-edge player in the biotechnology sector, has captured the attention of investors with its promising pipeline of peptide therapeutics targeting hematology, blood disorders, and..
In the competitive landscape of the healthcare sector, Evotec SE (EVO) stands out as a dynamic player in the drug discovery and development arena. Headquartered in Hamburg, Germany, Evotec operates..
Dyne Therapeutics, Inc. (NASDAQ: DYN), a promising player in the biotechnology sector, has been capturing the attention of investors with a compelling potential upside of 145.46%. As a clinical-stage company..
Guardian Pharmacy Services, Inc (GRDN) is a notable player in the healthcare sector, specifically within the medical care facilities industry. With its headquarters in Atlanta, Georgia, the company is renowned..
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is making waves in the biotechnology sector with its promising portfolio of therapeutic antibodies targeting severe inflammatory, allergic, and autoimmune diseases. Headquartered in Hampton, New..
Investors with a keen eye on the biotechnology sector will find Edgewise Therapeutics, Inc. (NASDAQ: EWTX) a compelling prospect. With its focus on pioneering treatments for muscle disorders, Edgewise is..
Janux Therapeutics, Inc. (NASDAQ: JANX), a clinical-stage biopharmaceutical innovator, is making waves in the biotechnology sector with its pioneering immunotherapy solutions. Headquartered in San Diego, California, this company is at..
In the ever-evolving landscape of healthcare investments, Organon & Co. (NYSE: OGN) presents a compelling opportunity for investors seeking exposure to the drug manufacturing sector. With its extensive portfolio focusing..
